|
|
National Research Corporation (NRC) |
|
|
|
National Research's Yearly EPS from Cont. Operations Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
|
NRC Annual EPS from Cont. Operations Growth |
2023
|
2022
|
2021
|
2020
|
2019
|
Y / Y Annual EPS from Cont. Operations Change |
-1.56 % |
-12.93 % |
-0.68 % |
13.85 % |
20.37 % |
Annual EPS from Cont. Operations (in $) |
$1.26 |
$1.28 |
$1.47 |
$1.48 |
$1.30 |
Annual EPS from Cont. Operations Growth
Comment |
National Research Corporation experienced detoriation of Annual EPS from Cont. Operations for the fiscal year ended 2023 by -1.56% to $ 1.26 , compare to $ 1.28 in Annual EPS from Cont. Operations reported in the previous year. National Research's EPS from Cont. Operations decline slowed form -12.93 % contraction in the fiscal year 2022.
National Research Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual EPS from Cont. Operations within Healthcare Sector | Y/Y EPS from Cont. Operations Growth % | 2023 Annual EPS from Cont. Operations | Cassava Sciences Inc | | | |